These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 6843911)

  • 1. Changes in receptor levels in brain during experimental copper deficiency.
    Nutr Rev; 1983 Jan; 41(1):19-20. PubMed ID: 6843911
    [No Abstract]   [Full Text] [Related]  

  • 2. Drug-induced alterations in neurotransmitter receptor binding and function.
    Enna SJ; Ferkany JW; Strong R
    Adv Biochem Psychopharmacol; 1980; 21():253-63. PubMed ID: 6246740
    [No Abstract]   [Full Text] [Related]  

  • 3. Alterations in neurotransmitter receptor binding in discrete areas of the copper-deficient rat brain.
    Feller DJ; O'Dell BL; Bylund DB
    J Neurochem; 1982 Feb; 38(2):519-24. PubMed ID: 6286887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurotransmitter, opiate and benzodiazepine receptor binding of tetrahydroisoquinolines and beta-carbolines in brain membranes.
    Nimit Y; Schulze I; Cashaw JL; Ruchirawat S; Davis VE
    Prog Clin Biol Res; 1982; 90():311-20. PubMed ID: 6287493
    [No Abstract]   [Full Text] [Related]  

  • 5. Receptor-binding changes in copper-deficient rats.
    Geiger JD; Seth PK; Klevay LM; Parmar SS
    Pharmacology; 1984; 28(4):196-202. PubMed ID: 6328549
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction of a muscarinic cholinergic agonist on acetylcholine and dopamine receptors in the monkey brain studied with positron emission tomography.
    Hartvig P; Nordberg A; Torstenson R; Sjöberg P; Fasth KJ; Långström B
    Dement Geriatr Cogn Disord; 2002; 13(4):199-204. PubMed ID: 12006729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of focal cerebral ischaemia on modulatory neurotransmitter receptors in the rat brain: an autoradiographic study.
    Rogozinska K; Skangiel-Kramska J
    J Chem Neuroanat; 2010 Nov; 40(3):232-8. PubMed ID: 20600826
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Changes in the energy status of the brain structures in pharmacological exposures].
    Arkhipov VI; Bulantsev AIu
    Farmakol Toksikol; 1986; 49(3):115-9. PubMed ID: 2873050
    [No Abstract]   [Full Text] [Related]  

  • 9. Absence of dopamine and muscarinic receptors on human lymphocytes.
    Maloteaux JM; Waterkein C; Laduron PM
    Arch Int Pharmacodyn Ther; 1982 Jul; 258(1):174-6. PubMed ID: 7138143
    [No Abstract]   [Full Text] [Related]  

  • 10. Neuroleptic affinities for human brain receptors and their use in predicting adverse effects.
    Richelson E
    J Clin Psychiatry; 1984 Aug; 45(8):331-6. PubMed ID: 6146602
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brain neurotransmitters and neuropeptides in Parkinson's disease.
    Rinne UK; Rinne JO; Rinne JK; Laakso K; Lönnberg P
    Acta Physiol Pharmacol Latinoam; 1984; 34(3):287-99. PubMed ID: 6099688
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transmitter receptor alterations in Parkinson's disease.
    Calne DB; Stoessl AJ
    Adv Neurol; 1987; 45():45-9. PubMed ID: 2881449
    [No Abstract]   [Full Text] [Related]  

  • 13. Rat anococcygeus: a dynamic smooth muscle preparation for experimental pharmacology.
    Kulkarni SK; Sharma A
    Methods Find Exp Clin Pharmacol; 1994; 16(6):379-85. PubMed ID: 7837828
    [No Abstract]   [Full Text] [Related]  

  • 14. Amitriptylinoxide: receptor-binding profile compared with other antidepressant drugs.
    Borbe HO; Zierenberg O
    Pharmacopsychiatry; 1985 Sep; 18(5):314-9. PubMed ID: 2996040
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discrete regional distribution of biochemical markers for the dopamine, noradrenaline, serotonin, GABA and acetylcholine systems in the monkey brain (Cebus Apella). Effects of stress.
    Häggström JE; Sjöquist B; Eckernäs SA; Ingvast A; Gunne LM
    Acta Physiol Scand Suppl; 1984; 534():1-27. PubMed ID: 6150601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drastic decrease in dopamine receptor levels in the striatum of acetylcholinesterase knock-out mouse.
    Hrabovska A; Farar V; Bernard V; Duysen EG; Brabec J; Lockridge O; Myslivecek J
    Chem Biol Interact; 2010 Jan; 183(1):194-201. PubMed ID: 19818744
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of dietary or genetic copper deficiency on brain catecholamines, trace metals and enzymes in mice and rats.
    Prohaska JR; Smith TL
    J Nutr; 1982 Sep; 112(9):1706-17. PubMed ID: 6286908
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Profile of the adverse effects of neuroleptic drugs in relation to its receptor binding].
    Gerlach J
    Nord Med; 1987; 102(4):120-3. PubMed ID: 2884620
    [No Abstract]   [Full Text] [Related]  

  • 19. [The comparative clinico-experimental characteristics of aminostigmine and galanthamine used for treating poisonings by choline-blocking substances].
    Prozorovskiĭ VB; Velikova VD; Pshenkina NN; Vasilenko ET
    Eksp Klin Farmakol; 1996; 59(1):64-7. PubMed ID: 8704639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dopaminergic regulation of muscarinic receptor binding in the corpus striatum.
    Ehlert FJ; Roeske WR; Yamamura HI
    Proc West Pharmacol Soc; 1981; 24():93-5. PubMed ID: 7255494
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.